Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XAIR

Beyond Air Inc

Apr 17 • 04:00PM ET

0.5440

+0.0988 22.19 %

Healthcare • Medical Devices • USA • NASD

Apr 17, 8:30 PMUSPTO Notice of Allowance for tumor gas-delivery patent drives XAIR's 22% surge.

Peers: MDT ABT ISRG SYK BSX EW INSP PEN NVCR TMDX

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.42	Insider Own	5.88%	Shs Outstand	10.53M	Perf Week	-30.96%
Market Cap	5.73M	Forward P/E	-	EPS next Y	-1.75	Insider Trans	0.00%	Shs Float	9.91M	Perf Month	-32.59%
Enterprise Value	11.64M	PEG	-	EPS next Q	-0.54	Inst Own	15.44%	Short Float	1.14%	Perf Quarter	-68.37%
Income	-31.00M	P/S	0.83	EPS this Y	72.16%	Inst Trans	-1.13%	Short Ratio	0.28	Perf Half Y	-78.91%
Sales	6.92M	P/B	0.56	EPS next Y	54.46%	ROA	-87.43%	Short Interest	0.11M	Perf YTD	-25.07%
Book/sh	0.97	P/C	0.32	EPS next 5Y	51.60%	ROE	-240.75%	52W High	5.84 -90.69%	Perf Year	-88.65%
Cash/sh	1.69	P/FCF	-	EPS past 3/5Y	25.75% 17.29%	ROIC	-99.00%	52W Low	0.43 26.51%	Perf 3Y	-99.57%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 21.66%	Gross Margin	1.83%	Volatility	19.76% 11.42%	Perf 5Y	-99.50%
Dividend TTM	-	EV/Sales	1.68	EPS Y/Y TTM	74.30%	Oper. Margin	-419.51%	ATR (14)	0.09	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.77	Sales Y/Y TTM	129.04%	Profit Margin	-447.75%	RSI (14)	35.82	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	5.12	EPS Q/Q	71.23%	SMA20	-20.83%	Beta	0.28	Target Price	7.75
Payout	-	Debt/Eq	2.91	Sales Q/Q	104.66%	SMA50	-35.20%	Rel Volume	4.30	Prev Close	0.45
Employees	61	LT Debt/Eq	2.86	Earnings	Feb 13 BMO	SMA200	-69.02%	Avg Volume	398.93K	Price	0.54
IPO	Sep 23, 2016	Option/Short	No / Yes	EPS/Sales Surpr.	-13.26% 1.89%	Trades		Volume	1,715,505	Change	22.19%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-17-25	Initiated	D. Boral Capital	Buy	$11
Jun-25-24	Downgrade	BTIG Research	Buy → Neutral
Jul-28-23	Initiated	Piper Sandler	Overweight	$10
Jun-15-23	Initiated	BTIG Research	Buy	$15
Apr-28-21	Initiated	Truist	Buy	$12
Oct-22-19	Initiated	Oppenheimer	Outperform	$9

Apr-15-26 08:00AM	Beyond Air to Participate in the D. Boral Capital Global Conference 2026 (GlobeNewswire) -11.58%
Apr-01-26 09:00AM	Beyond Air Expands Commercial Access for LungFit PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO) (GlobeNewswire)
Mar-26-26 04:05PM	Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO (GlobeNewswire) -6.74%
Mar-17-26 04:35PM	Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial (GlobeNewswire)
Mar-11-26 07:00AM	Beyond Air to Participate in the 38th Annual Roth Conference in March (GlobeNewswire)
07:30AM	Loading…
Mar-10-26 07:30AM	Beyond Air Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. (GlobeNewswire)
Mar-04-26 05:39AM	Beyond Air Inc (XAIR) Expands Focus on Nitric Oxide Therapies (Insider Monkey)
Feb-20-26 08:00PM	Beyond Air Inc (XAIR) Q3 2026 Earnings Call Highlights: Impressive Revenue Growth and Strategic ... (GuruFocus.com) -7.34%
08:00AM	Beyond Air Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections (GlobeNewswire)
Feb-13-26 04:32PM	Beyond Air, Inc. Q3 2026 Earnings Call Summary (Moby)
07:30AM	Beyond Air Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-04-26 08:00AM	Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026 (GlobeNewswire) -5.22%
Jan-27-26 04:05PM	Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences (GlobeNewswire) -7.53% -5.93%
Jan-26-26 04:05PM	Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast (GlobeNewswire) -9.88%
Jan-14-26 08:30AM	Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -14.16%
01:40PM	Loading…
Jan-13-26 01:40PM	Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments (Benzinga) +150.00%
07:30AM	XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership (GlobeNewswire)
Dec-30-25 07:30AM	Beyond Air Appoints Dan Moorhead as Chief Financial Officer (GlobeNewswire)
Dec-17-25 07:30AM	Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Germany and Brazil (GlobeNewswire)
Nov-26-25 04:30PM	Beyond Air Announces Transition of Chief Financial Officer (GlobeNewswire)
Nov-11-25 12:02AM	Beyond Air Inc (XAIR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com) -16.09%
Nov-10-25 04:05PM	Beyond Air Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-05-25 08:00AM	Beyond Air Secures Up to $32 Million to Accelerate Growth (GlobeNewswire)
Oct-23-25 08:00AM	Beyond Air Schedules Second Fiscal Quarter 2026 Financial Results Conference Call and Webcast (GlobeNewswire)
Sep-22-25 08:00AM	Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference (GlobeNewswire) +5.38%
Sep-08-25 03:55PM	Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds (GlobeNewswire) +49.77%
08:00AM	NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults (GlobeNewswire)
Sep-03-25 08:00AM	Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-20-25 08:00AM	Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Japan (GlobeNewswire) -6.55%
Aug-13-25 03:11AM	Beyond Air Inc (XAIR) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Expansion ... (GuruFocus.com) -22.47%
05:35PM	Loading…
Aug-12-25 05:35PM	Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Beyond Air Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-11-25 09:45AM	Beyond Air Inc (XAIR) Q1 2026 Earnings Report Preview: What To Expect (GuruFocus.com) +5.33%
Aug-07-25 06:20PM	AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates (Zacks) +5.63%
Jul-25-25 08:00AM	Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast (GlobeNewswire)
Jul-22-25 07:30AM	Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc. (GlobeNewswire)
Jun-26-25 09:55AM	Here's Why Beyond Air (XAIR) Could be Great Choice for a Bottom Fisher (Zacks) -6.47%
Jun-18-25 03:01AM	Beyond Air Inc (XAIR) (Q4 2025) Earnings Call Highlights: Revenue Soars Amidst Strategic Global ... (GuruFocus.com) -29.02%
Jun-17-25 05:15PM	Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates (Zacks) +58.69%
04:01PM	Beyond Air Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Jun-16-25 09:16AM	Beyond Air Inc (XAIR) Q4 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
08:00AM	Beyond Air Submits FDA PMA Supplement for Next Generation LungFit PH (GlobeNewswire)
May-29-25 08:15AM	Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
May-28-25 05:20PM	Veeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates (Zacks)
May-20-25 08:00AM	Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast (GlobeNewswire)
Apr-24-25 04:05PM	Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO) (GlobeNewswire)
Apr-21-25 04:05PM	NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism (GlobeNewswire)
Apr-15-25 04:05PM	NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board (GlobeNewswire)
Apr-09-25 04:05PM	Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit GO at Home (GlobeNewswire) +11.63%
Apr-01-25 08:00AM	NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer's Disease and Reinforcing Platform's Strength Across Neurological Disorders (GlobeNewswire) -8.22%
Mar-31-25 08:00AM	Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site (GlobeNewswire)
Mar-24-25 04:05PM	NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy (GlobeNewswire) +5.63%
Mar-23-25 08:38AM	Beyond Air (XAIR): Among the Penny Stocks With Huge Upside Potential According to Analysts (InsiderMonkey)
Mar-11-25 07:30AM	Beyond Air Announces Agreements Expanding Global Distribution of LungFit PH (GlobeNewswire)
Mar-06-25 04:05PM	Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences (GlobeNewswire) -6.06%
Feb-10-25 04:05PM	Beyond Air Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire) +5.37% -6.49%
Feb-07-25 07:10AM	Beyond Air Inc (XAIR) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-05-25 09:29AM	Beyond Air Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement (GlobeNewswire)
Jan-27-25 04:05PM	Beyond Air Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast (GlobeNewswire) -7.83%
Jan-24-25 09:15AM	Beyond Air Announces LungFit PH Receives Market Authorization in Australia (GlobeNewswire)
Jan-06-25 08:00AM	Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 (GlobeNewswire)
Dec-03-24 04:05PM	Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy (GlobeNewswire) +7.85% -8.67%
Dec-02-24 07:30AM	Beyond Air Receives CE Mark in Europe for the LungFit PH System (GlobeNewswire)
Nov-26-24 07:30AM	NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board (GlobeNewswire) +22.16%
Nov-14-24 04:05PM	Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +9.71% -5.38%
Nov-11-24 04:05PM	Beyond Air Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire) +7.64%
07:00AM	Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Nov-08-24 07:06AM	Beyond Air Inc (XAIR) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com) -6.86%
Oct-29-24 04:22PM	Beyond Air Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast (GlobeNewswire) +11.65% +8.78%
Oct-07-24 07:00AM	Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire) -5.45%
Oct-02-24 07:30AM	Beyond Air Partners with Healthcare Links to Expand Access to LungFit PH System Through Group Purchasing Organizations and Integrated Delivery Networks (GlobeNewswire) +10.57%
Sep-28-24 07:40AM	Beyond Air to sell 40.39M shares at 51c in private placement (TipRanks)
07:35AM	Beyond Air terminates loan, security agreements with Avenue Capital (TipRanks)
Sep-27-24 07:34AM	Beyond Air Provides LungFit PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed (GlobeNewswire)
07:32AM	Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital (GlobeNewswire)
07:30AM	Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
Sep-23-24 08:00AM	Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference (GlobeNewswire) -6.08%
Aug-06-24 04:05PM	Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire) -17.38%
Jul-31-24 04:15PM	Beyond Air Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia (GlobeNewswire) -5.16%
Jul-23-24 04:05PM	Beyond Air to Report First Fiscal Quarter 2025 Financial Results on August 6 (GlobeNewswire) +5.29%
Jul-16-24 04:05PM	Beyond Air To Participate in the BTIG Virtual Biotechnology Conference 2024 (GlobeNewswire)
Jul-10-24 09:55AM	Beyond Air (XAIR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks) +5.59%
Jun-26-24 08:01AM	Beyond Air, Inc. (NASDAQ:XAIR) Q4 2024 Earnings Call Transcript (Insider Monkey)
Jun-25-24 10:31AM	Jefferies Just Raised Its Price Target on Nvidia (NVDA) Stock (InvestorPlace) -51.54%
08:28AM	Why Is Beyond Air (XAIR) Stock Down 22% Today? (InvestorPlace)
07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jun-24-24 08:53PM	XAIR Stock Earnings: Beyond Air Beats EPS, Misses Revenue for Q4 2024 (InvestorPlace) +8.06%
05:25PM	Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:15PM	Beyond Air Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Jun-13-24 04:05PM	Beyond Air Appoints David Webster as Chief Commercial Officer (GlobeNewswire)
Jun-03-24 07:00AM	Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO) (GlobeNewswire) -8.59%
May-23-24 04:09PM	Beyond Air Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast (GlobeNewswire) -9.50%
May-01-24 07:00AM	Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting (GlobeNewswire)
Mar-21-24 12:00PM	Beyond Air (XAIR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) +5.84%
Mar-20-24 09:00AM	Beyond Air Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants (GlobeNewswire)
Feb-13-24 08:51AM	Beyond Air, Inc. (NASDAQ:XAIR) Q3 2024 Earnings Call Transcript (Insider Monkey) -17.67%
Feb-12-24 04:05PM	Beyond Air Reports Financial Results for Third Quarter of Fiscal Year 2024 (GlobeNewswire) +14.97%
Jan-18-24 08:00AM	Beyond Air Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast (GlobeNewswire) -5.02%
Dec-27-23 07:30AM	Beyond Cancer Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors (GlobeNewswire)
Dec-21-23 01:40AM	Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc (GuruFocus.com) +12.04%

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lisi Steven A.	CEO and Chairman of the Board	Jul 21 '25	Buy	3.25	6,000	19,491	3,327,411	Jul 23 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

XAIR

Beyond Air Inc

Upgrade your Finviz experience